This report is about the fast-growing worldwide market for next-generation
sequencing (NGS) tools and services. NGS systems makers are effectively
driving down the cost of sequencing a human genome. Once the cost of full
genome sequencing drops to $1,000 or less, scientists will be able sequence
human genomes at the massive scale needed to better understand human variation
and help open the gateway to personalized medicine. New NGS markets in
medical, agriculture, bio-fuels, forensics, or others will emerge.
This must-have report discusses its interesting topics with key findings.
Within a short time, the commercial NGS systems have seen a rapid uptake as
these systems have been deployed into large genome centers, non-profit
institutes, cancer research centers, drug makers, diagnostics firms and
service providers worldwide. The report estimates that the total NGS tools and
service market will reach $1.3 billion in 2011 and grow at a high double digit
growth rate over the next 5-years. The report shows that various NGS systems
are available to fill nearly every customer need, from high production
volumes, to small scale, or to special niches.
The study reviews the technologies that these new NGS machines use and what
kinds of applications and research projects that the scientists are doing. The
report discusses government research grants and private initiatives. The
report studies NGS service providers that outsource to pharma and biotech
companies or other customers because the technologies might help them become
more productive faster. Service providers such as Complete Genomics, GATC,
PerkinElmer and others are convenient resources.
Takeda Pacific offers this report in an interactive PDF format. The
interactive feature uses hyperlinks that enable the reader to click the mouse
to jump from Table of Contents items to sections inside the report. The
hyperlinks also allow the reader to click on links to Internet information.
This report is for business executives, entrepreneurs, venture capitalists,
investors, product managers, research managers, business development managers,
government officials and other decision makers. The research study discusses
NGS products and services from Illumina, Life Technologies, Roche 454, Helicos
Biosciences, Ion Torrent, Pacific Biosciences, Oxford Nanopore Technologies,
The report uses 61 figures and tables to illustrate the findings. The study
features convenient tables that help the reader scan the details of key
trends, market segmentation, forecasts, M&As, alliances, grant funding,
patents and so forth. The study profiles the activities of 19 companies.
About Takeda Pacific
Analysts at Takeda Pacific developed this report. The company provides
business consulting that focuses on facilitating business development and
market research projects. The business projects may involve European, Japanese
and North American Life Science companies. Since it' s founding in late 1992,
TP has reviewed or analyzed thousands of life Science and technology firms for
its clients. Takeda Pacific has produced numerous industry reports about
emerging pharma, biotech, medical devices and technology companies and
markets.Takeda Pacific also offers follow-up consulting or custom research
consulting to assist in your business development or benchmarking, market
- Date Published: May 2011
- Authors: Jay K. Myers, Paula Mitchell Myers
- Total Number of Pages: 161 (can be printed; fully searchable PDF format)